Made-in-Alberta vaccine and drug development pipeline gets funding

Alberta invests $55.1M to taking vaccines, antiviral drugs from discovery to manufacturing

Made-in-Alberta vaccine and drug development pipeline gets fundingAlberta is building a better pipeline, but this one’s not for oil and gas products – it’s for vaccines and therapeutic drugs to fight viral diseases. The province announced a $55.1-million grant on Wednesday for University of Alberta research on ways to prevent and treat COVID-19, including $15 million for vaccine projects and $10 million for studies…

The new drug-price reform not what the doctor ordered

The well-being of patients is at risk

The new drug-price reform not what the doctor orderedBy Krystle Wittevrongel and Maria Lily Shaw Montreal Economic Institute A highly-contested drug-price reform is set to come into effect in Canada in January 2022. Critics of the major overhaul, including patient groups, doctors, and academics, are hopeful that the new federal cabinet will take their concerns to heart and rather than stifle pharmaceutical innovation,…

Promising chemotherapy treatment for bladder cancer enters human trials

A rejected patent application nearly derailed years of research, but support from experts saved the day

Promising chemotherapy treatment for bladder cancer enters human trialsIn 2015, University of Alberta cancer researcher Jack Tuszynski learned that his patent application for a promising chemotherapy treatment for people suffering from metastatic bladder cancer had been rejected by the U.S. Patent Office. “That was it. I thought, ‘We can’t proceed, we’re done, we spent almost a decade working on this and it’s a no go,’”…

Research bringing us closer to a cure for diabetes

November is National Diabetes Awareness Month

Research bringing us closer to a cure for diabetesAs part of the celebrations, we're revisiting five great stories showcasing the breadth of work being done at the University of Alberta in the journey towards a cure. For many of the 465 million people around the world living with diabetes, insulin is a lifeline. Since their bodies don’t produce enough of the hormone naturally…

Obesity, Type 2 diabetes leading risk factors for severe COVID-19

Link could hold the key to improving immune responses against COVID-19 and other viruses

Obesity, Type 2 diabetes leading risk factors for severe COVID-19A little-understood link between insulin resistance in cells and obesity could hold the key to improving immune responses against COVID-19 and other viruses, according to University of Alberta researcher Sue Tsai. “We hypothesize that insulin resistance in immune cells such as B cells is a major link between obesity and an impaired antiviral response, leading…

Edmonton-based partnership poised to close Canada’s drug supply gaps

Initiative could transform Alberta into a powerhouse in the development of life-saving therapies

Edmonton-based partnership poised to close Canada’s drug supply gapsA gap in homegrown drug manufacturing means that Canadians are at the mercy of the global supply chain when it comes to ensuring they have access to the drugs they need. Around 80 per cent of the raw ingredients for the world’s drugs are made in only two countries: China and India, according to a…

Biomanufacturing partnership boosts Canada’s vaccine capacity

New partnership ensures vaccine makers now have an option to manufacture their products domestically

Biomanufacturing partnership boosts Canada’s vaccine capacityVaccine makers, medical researchers and pharmaceutical companies now have a new full-service option to get their products manufactured in Canada, thanks to a partnership announced this week. The U of A’s Alberta Cell Therapy Manufacturing (ACTM) facility has signed a memorandum of understanding with The Ottawa Hospital’s Biotherapeutics Manufacturing Centre (BMC) and BioCanRx, a Canada-wide research network to develop…

Let’s have permanently quicker drug approvals

On average, drug approvals take three months longer in Canada than in the U.S. and one month longer than in Europe

Let’s have permanently quicker drug approvalsBy Maria Lily Shaw and Krystle Wittevrongel Montreal Economic Institute The past year has shown us beyond the shadow of a doubt that human ingenuity is a match for the greatest of challenges. The rapid development and mass production of several COVID-19 vaccines are proof of our remarkable capacity for innovation. Pharmaceutical innovation, one of…

Bright future for cannabis as perspectives shift

It will be interesting to see how the market evolves and how Canadians will (or won’t) embrace cannabis in a post-pandemic economy

Bright future for cannabis as perspectives shiftIn 2019, the cannabis sector in Canada had its bubble burst. But its comeback appears promising. Players in the field are slowly getting their footing back and settling into a North American market that’s different from its pre-pandemic predecessor. More mergers and acquisitions are pointing to a more mature marketplace. But with cannabis, Canada and…

Data highlights value of supervised drug consumption services

Increased visits play a role in a decrease in overdose deaths

Data highlights value of supervised drug consumption servicesResearchers have found a link between increased visits to supervised consumption sites in Alberta and decreased fentanyl-related overdose deaths. Using publicly available opioid-response reports from the province of Alberta, the University of Alberta researchers looked at the number of fentanyl-related overdose deaths by quarter from 2017 to 2020, as well as the number of visits…
1 2 3 13